F
Ford Motor Company
F has the edge over MCFT overall, supported by stronger modeled upside and lower modeled downside.
MCFT
MasterCraft Boat Holdings, Inc.
MCFT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
MCFT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Healthy | |
| Strong |
MCFT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
MCFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $1.21 | -94% |
| Fair | 9.3x | $1.67 | -92% |
| Expensive | 24x | $4.36 | -80% |
| Current | 120x | $21.59 | — |
Historical ranges are pointers, not guarantees.
MCFT's PE is in its expensive range at 120x.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MCFT Forward outlook
There aren't enough analyst estimates for MCFT to show an outlook.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
MCFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -81% |
| Q2 2026 | -$0.10 | -123% |
| Q1 2026 | $0.68 | +$1.05 |
| Q4 2025 | $0.96 | +$1.34 |
| Q3 2025 | $0.97 | +$1.18 |
| Q2 2025 | $0.44 | -4.3% |
| Q1 2025 | -$0.37 | -117% |
| Q4 2024 | -$0.38 | -112% |
MCFT has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
MCFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.1M | +123% |
| Q2 2026 | $129.9M | +63% |
| Q1 2026 | $78.2M | +3% |
| Q4 2025 | $71.8M | +13% |
| Q3 2025 | $69M | +5.6% |
| Q2 2025 | $79.5M | +18% |
| Q1 2025 | $76M | -21% |
| Q4 2024 | $63.4M | -36% |
MCFT has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.8% | +2.3 points |
| Q2 2026 | -4.9% | -12 points |
| Q1 2026 | -1.7% | -7.1 points |
| Q4 2025 | 3.8% | +3.5 points |
| Q3 2025 | 5.5% | +3.9 points |
| Q2 2025 | 7.5% | +25 points |
| Q1 2025 | 5.4% | +1.2 points |
| Q4 2024 | 0.3% | -6.8 points |
MCFT has the edge over F on profitability, with a higher operating margin.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over MCFT on cash flow, with more consistent year-over-year improvement.
MCFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.9M | +$12.8M |
| Q2 2026 | $14.6M | -18% |
| Q1 2026 | $3.8M | -13% |
| Q4 2025 | $14M | +245% |
| Q3 2025 | -$9.9M | -5083% |
| Q2 2025 | $17.9M | +$31.4M |
| Q1 2025 | $4.3M | +$5.2M |
| Q4 2024 | $4M | -83% |
MCFT still generates free cash flow, though less than at its 2023 peak: $35M over the past year.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over MCFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
MCFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +51% | +8.2M shares |
| 1 year | +48% | +7.9M shares |
| 3 years | +39% | +6.8M shares |
| 5 years | +28% | +5.3M shares |
| Available history | +30% | +5.5M shares |
MCFT has 24M diluted shares, up 48% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q2 2026 | $12,000 |
| Q1 2026 | — |
| Q4 2025 | $15,000 |
| Q3 2025 | $2.3M |
| Q2 2025 | $4.5M |
| Q1 2025 | $749,000 |
| Q4 2024 | $749,000 |
MCFT spent $5M buying back its own shares over the past year, down 42% from the year before.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over MCFT on leverage, with a lower net debt burden relative to earnings.
MCFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -3.5x | Net Cash |
| Q1 2026 | -3.7x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -8.8x | Net Cash |
| Q4 2024 | -10.1x | Net Cash |
MCFT has more cash than debt.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
MCFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 32.4 | Neutral |
MCFT's weekly RSI is 49 (neutral) and its Stochastic is 32 (neutral).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
MCFT PE vs Consumer Cyclical Sector
| Metric | MCFT | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 18x | 565% above |
| PE % | 100 | 47 | 53 pts above |
MCFT is trading at 120x earnings, a 565% premium to the Consumer Cyclical sector's median of 18x.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
MCFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.4 | 6.1% above |
| 20 week MA | $22.3 | 3.2% below |
| 50 week MA | $22.1 | 2.4% below |
| 100 week MA | $20.5 | 5.2% above |
| 200 week MA | $22.0 | 1.8% below |
MCFT has the edge over F on trend strength, trading above more of its moving averages.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.
MCFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.4 | $26.7 | +73% |
| 2021 | $26.7 | $26.3 | -1.6% |
| 2022 | $26.3 | $26.2 | -0.3% |
| 2023 | $26.2 | $22.6 | -14% |
| 2024 | $22.6 | $18.7 | -17% |
| 2025 | $18.7 | $19.5 | +4.1% |
| 2026 YTD | $19.5 | $21.6 | +11% |
MCFT has the edge over F on returns for 2026, with the stronger performance.